Natural History Study Protocol in PMM2-CDG (CDG-Ia) | MicrobiomeTrials← Back to trialsNCT03173300
Natural History Study Protocol in PMM2-CDG (CDG-Ia)
CompletedOBSERVATIONAL
Trial Details
Start: 2018-01-08Est. Completion: 2026-04-09
Enrollment target: 139 participants Locations- Mayo Clinic College of Medicine, Rochester, Minnesota, United States
- Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, United States
- Seattle Children's Hospital, Seattle, Washington, United States
- University Hospital Leuven, Leuven, Belgium, Belgium
- General University Hospital in Prague, Prague, Czechia
- Necker Enfants-Malades Hospital, Paris, France
- University Hospital of Catania, Catania, Italy
- Radboud University Nejmegen Medical Center, Nijmegen, Netherlands
- Mother and Child Institute (Instytut Matki i Dziecka), Warsaw, Poland
- Centro Hospitalar do Porto, Porto, Portugal
- Hospital Sant Joan de Déu, Barcelona, Spain
Other microbiome trials you might be interested in
Pmm2-CDGPhosphomannomutase 2 Deficiency
The goal of this clinical trial is to provide continued access to GLM101 to treat PMM2-CDG in people who have previously…
Minneapolis, United StatesCompleted Sep 2029
Phosphomannomutase 2 DeficiencyPMM2-CDG
This study is evaluating the safety, effectiveness, and how the body absorbs, distributes, and eliminates GLM101, for pa…
Minneapolis, United StatesEst. completion Sep 30, 2026